Kuehner F, Stubenrauch F
Viruses. 2022; 14(5).
PMID: 35632695
PMC: 9143700.
DOI: 10.3390/v14050953.
Gao J, Gu Z
Front Pharmacol. 2022; 13:832732.
PMID: 35308207
PMC: 8931476.
DOI: 10.3389/fphar.2022.832732.
Kaupang A, Hansen T
PPAR Res. 2020; 2020:9657380.
PMID: 32695150
PMC: 7351019.
DOI: 10.1155/2020/9657380.
Davalos-Salas M, Montgomery M, Reehorst C, Nightingale R, Ng I, Anderton H
Nat Commun. 2019; 10(1):5291.
PMID: 31757939
PMC: 6876593.
DOI: 10.1038/s41467-019-13180-8.
Bai F, Liu Y, Tu T, Li B, Xiao Y, Ma Y
Lipids Health Dis. 2019; 18(1):109.
PMID: 31077199
PMC: 6511207.
DOI: 10.1186/s12944-019-1059-7.
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.
Liang N, Damdimopoulos A, Goni S, Huang Z, Vedin L, Jakobsson T
Nat Commun. 2019; 10(1):1684.
PMID: 30975991
PMC: 6459876.
DOI: 10.1038/s41467-019-09524-z.
Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors.
Korbecki J, Bobinski R, Dutka M
Inflamm Res. 2019; 68(6):443-458.
PMID: 30927048
PMC: 6517359.
DOI: 10.1007/s00011-019-01231-1.
CRY1/2 Selectively Repress PPARδ and Limit Exercise Capacity.
Jordan S, Kriebs A, Vaughan M, Duglan D, Fan W, Henriksson E
Cell Metab. 2017; 26(1):243-255.e6.
PMID: 28683290
PMC: 5546250.
DOI: 10.1016/j.cmet.2017.06.002.
Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis.
Lake A, Chaput A, Novak P, Cherrington N, Smith C
Biochem Pharmacol. 2016; 122:62-71.
PMID: 27836672
PMC: 5129657.
DOI: 10.1016/j.bcp.2016.11.006.
Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.
Olivares A, Moreno-Ramos O, Haider N
J Exp Neurosci. 2016; 9(Suppl 2):93-121.
PMID: 27168725
PMC: 4859451.
DOI: 10.4137/JEN.S25480.
Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.
Lee W, Kim J
PPAR Res. 2015; 2015:271983.
PMID: 26587015
PMC: 4637490.
DOI: 10.1155/2015/271983.
Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.
Long M, van den Berg P, Russell J, Singh P, Battaglia S, Campbell M
Nucleic Acids Res. 2015; 43(15):7330-48.
PMID: 26117541
PMC: 4551916.
DOI: 10.1093/nar/gkv642.
The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.
Rodriguez J, Liao J, He J, Schisler J, Newgard C, Drujan D
Mol Cell Endocrinol. 2015; 413:36-48.
PMID: 26116825
PMC: 4523404.
DOI: 10.1016/j.mce.2015.06.008.
Airway epithelial cell PPARγ modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice.
Solleti S, Simon D, Srisuma S, Arikan M, Bhattacharya S, Rangasamy T
Am J Physiol Lung Cell Mol Physiol. 2015; 309(3):L293-304.
PMID: 26024894
PMC: 4525123.
DOI: 10.1152/ajplung.00287.2014.
Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.
Jo Y, Ryu D, Maida A, Wang X, Evans R, Schoonjans K
Hepatology. 2015; 62(5):1606-18.
PMID: 25998209
PMC: 4618256.
DOI: 10.1002/hep.27907.
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C, Li Y, Gow C, Wong M, Zha J, Yan C
J Biol Chem. 2014; 290(6):3666-79.
PMID: 25519902
PMC: 4319032.
DOI: 10.1074/jbc.M114.598797.
Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.
Wong M, Guo C, Zhang J
Am J Clin Exp Urol. 2014; 2(3):169-87.
PMID: 25374920
PMC: 4219314.
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
Rossger K, Charpin-El-Hamri G, Fussenegger M
Nat Commun. 2013; 4:2825.
PMID: 24281397
PMC: 3868331.
DOI: 10.1038/ncomms3825.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
Godoy P, Hewitt N, Albrecht U, Andersen M, Ansari N, Bhattacharya S
Arch Toxicol. 2013; 87(8):1315-530.
PMID: 23974980
PMC: 3753504.
DOI: 10.1007/s00204-013-1078-5.
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.
Adhikary T, Brandt D, Kaddatz K, Stockert J, Naruhn S, Meissner W
Oncogene. 2012; 32(44):5241-52.
PMID: 23208498
PMC: 3938163.
DOI: 10.1038/onc.2012.549.